Dorzolamide HCl (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Dorzolamide HCl drug offered from Bausch & Lomb Incorporated. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
NON-PROPRIETARY NAME: | Dorzolamide HCl |
SUBSTANCE NAME: | DORZOLAMIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-06-25 |
END MARKETING DATE: | 0000-00-00 |
Dorzolamide HCl HUMAN PRESCRIPTION DRUG Details:
Item Description | Dorzolamide HCl from Bausch & Lomb Incorporated |
LABELER NAME: | Bausch & Lomb Incorporated |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2009-06-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24208-485_185a8685-cd8b-4e08-b6e8-ec04fc83e405 |
PRODUCT NDC: | 24208-485 |
APPLICATION NUMBER: | ANDA090143 |
Other DORZOLAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: